Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.010
-0.010 (-0.98%)
At close: May 9, 2025, 4:00 PM
1.001
-0.009 (-0.91%)
After-hours: May 9, 2025, 6:41 PM EDT
Immunic Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Immunic stock have an average target of 13.2, with a low estimate of 5.00 and a high estimate of 28. The average target predicts an increase of 1,206.93% from the current stock price of 1.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunic stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
Buy | 2 | 2 | 2 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 7 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +890.10% | May 1, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +1,583.17% | Apr 30, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +494.06% | Apr 16, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +890.10% | Apr 15, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +1,583.17% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.72
from -1.00
EPS Next Year
-0.65
from -0.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 94.8M | ||
Avg | n/a | n/a | 34.0M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.44 | -0.33 | -0.36 | ||
Avg | -0.72 | -0.65 | -0.57 | ||
Low | -0.84 | -0.93 | -0.76 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.